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Days
post HCT
CMV
reactivation
(n¼26)
No CMV
reactivation
(n¼85)
p-values
%NK (median) 45 13.3% 17.2% p¼0.035
80 7.0% 11.3% p¼0.0015
%NK/PD-1
(median)
45 0.59% 0.42% ns
80 0.96% 0.37% p¼0.0003
%NK/IFN-g
(median)
45 2.7% 1.2% p¼0.03
80 1.8% 1.2% p¼0.03
%NK Perforin
(median)
45 60.2% 39.2% p¼0.04
80 25.4% 41.8% ns
%NK/Granzyme
(median)
45 91.3% 85.7% p¼0.02
80 89.8% 86.2% p¼0.04
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characterized by a failure to recover early thymopoiesis and
impairment of functional T cell recovery, compared to other
recipients of autologous or allogeneic transplants (Koman-
duri et al., Blood, 2007). We now report a more extensive
study of adult CBT recipients in whom thymopoiesis was
prospectively assessed by measuring T cell receptor excision
circles (TRECs) in the peripheral blood. Thymic function was
assessed prior to CBT, and at varying intervals thereafter. A
total of 71 adult CBT recipients were assessed prior to CBT
and also assessed at least once within the ﬁrst 180 days after
CBT. Of these recipients, 44 of 71 had detectable thymopoi-
esis prior to the start of conditioning (62%), while baseline
thymopoiesis was undetectable in others (38%). In CBT re-
cipients with detectable thymopoiesis at baseline, 32% had at
least one sample demonstrating detectable thymopoiesis by
six months post-transplant. In contrast, only 4% of subjects
with a negative baseline had any detectable thymopoiesis by
six months. These results suggest that the recovery of early
thymopoiesis within the ﬁrst six months of CBT in adults
may be dependent on functional thymopoiesis at baseline.
Univariate landmark of a subset of these CBT recipients
(n¼41) stratiﬁed by the recovery of thymopoiesis at six
months after CBT demonstrated that recovery of thymopoi-
esis was positively associated with overall survival (HR¼0.2,
95% conﬁdence interval 0.1-0.7, P¼0.01), and also with
decreased non-relapsed mortality (HR¼0.2, 95% conﬁdence
interval 0.1-0.9, p¼0.04). Larger studies of baseline thymo-
poiesis prior to hematopoietic transplantationwill be helpful
to conﬁrm these ﬁndings and ascertain how and why thy-
mopoiesis is preserved in a subset of patients, and to deter-
mine more precisely the relationship of baseline function
and post-CBT outcomes.
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Cytomegalovirus (CMV) infection represents a major
complication in hematopoietic stem cell transplantation
(HCT). There is accumulating evidence that immune re-
sponses to CMV infection involve the expansion of speciﬁc
subsets of NK cells largely driven by the activating receptor
NKG2C.
Under an IRB approved protocol (COH 09038), we prospec-
tively examined the reconstitution of NK cells post-HCT
(days 21, 30, 45, 80 and 120) with regards to their immu-
nophenotypes and functions. A total of 111 patients are
enrolled (median age: 54, range 19-70) who underwent HCT
from related (n¼49) or unrelated donors (n¼62) after either
fully ablative (n¼36) or reduced-intensity (n¼75) condi-
tioning. Donor (D)/Recipient (R) serostatus was D+/R+ in 69,D-/R+ in 33, and D+/R- in 6 pairs. Acute GVHD grade II-IV was
observed in 49 patients (47%). CMV reactivations were seen
in 26 patients (23.4%) with the median time of reactivation
on day 49, including 2 cases of CMV disease.
CMV reactivationwas signiﬁcantly associated with increased
%NK cells expressing PD-1, IFN-gamma, perforin, and gran-
zyme B (Table 1). More focused analysis on available day 80
samples (n¼75) demonstrated a signiﬁcant increase in NK
cells expressing NKG2C in patients with CMV reactivations
(24.2%, n¼17) compared with no reactivations (13.2%, n¼58,
p¼0.018), consistent with published reports. Among
NKG2C+NKcells, CMV reactivation was associated with
increased granzyme B (85.4% vs. 56.9%, p¼0.003) and Ki67
expression (7.0% vs. 2.9%, p¼0.03).
We further explored NK responses to CMV antigen by co-
culturing PBMC (day 80 samples) and pp65 peptide mix for
24 hours. There was no signiﬁcant change in %NKG2C+NK
cells before and after pp65 stimulation. Interestingly,
NKG2C-NK cells showed a response to pp65 stimulation in
their expression of CD137 (pre: 0.06% vs. post: 0.23%,
p¼0.005) and IFN-gamma (pre: 1.6% vs. post: 2.1%, p¼0.03 in
CMV reactivators), suggesting a potential role of NKG2C-NK
cells in CMV infections.
In summary, our data support that CMV reactivation is
associated with expansion (Ki67) and cytotoxic functions
(perforin, granzyme, IFN-gamma) of NK cells expressing
NKG2C following allogeneic HCT.201
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Poor reconstitution of T cell immunity after umbilical cord
blood transplantation (UCBT) results in susceptibility to viral
infections that require intact T cell immunity. Epstein Barr
